41 news items
Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma in CheckMate -9DW Trial
BMY
4 Jun 24
contains "forward-looking statements" within the meaning of the Private Securities Litigation
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
BMY
3 Jun 24
the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the research, development and commercialization
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
BMY
1 Jun 24
contains "forward-looking statements" within the meaning of the Private Securities Litigation
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma
BMY
30 May 24
contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 regarding
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
BMY
23 May 24
the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the research, development and commercialization
5143aq9bkv
BMY
16 May 24
of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the research, development and commercialization of pharmaceutical
z41iiq4z
BMY
15 May 24
contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 regarding
438pnlnkq03dafu6ih8rjwaqxqk2 jynacgnem4hm6s
BMY
10 May 24
contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things
8if9y72oezht9fp3qhn553 7ozgfui
BMY
26 Apr 24
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995
iim5yw5kmw2wk4yi4yqztz2clclk62wnrp2ox4uks
BMY
25 Apr 24
to the items above, the decrease was also due to lower litigation and other settlement income. The company reported on a non-GAAP basis net loss
h1ofhk38822ghxi2lrpxhfibb5auju364ksv4ldkci 3tftp66
ABBV
ATNM
AZN
19 Apr 24
not be taken as investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking
d3qsmdaeb2w6oujqhwtgbz8z70waxjgt2smdw
ATNM
AZN
BMY
18 Apr 24
Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking statements. Any statement that projects, foresees, expects
m1a1wuaan57emkgqq5ap363btlopsc1jo18rzu5ea485
ATNM
AZN
BMY
17 Apr 24
investment adviser. The content here is purely informational and should not be taken as investment advice. The Private Securities Litigation Reform Act
c1u6ka9a tz80j4fo71x0o356ylej3gqbdofdtrh2ce4k
BMY
12 Apr 24
, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known